CLC offers advice about
allocation of COVID-19 vaccines to cancer patients
July 30, 2020
Norman E. “Ned” Sharpless,
MD
Director
National Cancer Institute
9000 Rockville Pike
Bethesda, MD 20892
RE:
NOT-CA-20-080,
Request for Information (RFI): Seeking Stakeholder
Input on Scientific Gaps and Research Needs Related to
Delivery of Cancer-Related Care via Telehealth
Dear Dr. Sharpless:
The undersigned
organizations of the Cancer Leadership Council represent
cancer patients, providers, researchers, and caregivers.
We appreciate the opportunity to offer advice
about research needs and scientific gaps related to
cancer care delivered by telehealth. All of us
have been on a challenging journey during the current
coronavirus Public Health Emergency (PHE), learning how
to deliver and receive care by telehealth and preparing
for a future of quality telehealth after the pandemic.
We identify below some
opportunities for research on cancer care through
telehealth.
Identifying Patient
and Provider Preferences Regarding Services That Can
Be Delivered by Telehealth
The clinicians and
patients we represent embraced the option for providing
and receiving cancer care through telehealth safely and
timely during the COVID pandemic. Although many
practices saw their telehealth visits increase
dramatically early in the pandemic, some have shifted
visits back to the provider office. However, the
volume of telehealth visits remains above pre-pandemic
levels.
Since the pandemic
emergence, health care professionals and patients have
been identifying the types of visits and range of cancer
care services that can be delivered successfully through
telehealth. Many of our organizations are
soliciting input regarding clinician and patient
preferences, through formal and informal means. We
would like to share our findings with you and your team
at the National Cancer Institute (NCI) and strongly
encourage that our survey be continued and expanded with
NCI support. Real world experience with telehealth
during the pandemic must be collected and analyzed.
Researching Strategies
to Enhance Access Rather Than Worsen Disparities
The waiver of telehealth
requirements permits the delivery and reimbursement of
services by audio only. Although this flexibility
has ensured access to telehealth services for those who
face limits in their devices, software, or wireless
connection, it is an inadequate solution. We
encourage research that analyzes the limits on access to
the technology necessary for video telehealth among both
patients and clinicians because recent experience
suggests that technology issues are contributing to
disparities in access. Research should also
address potential solutions and the overall extent of
disparities in accessing telehealth, whether related to
technology or other barriers.
Researching Options to
Enhance Coordination of Care Through Telehealth
Cancer patients receiving
telehealth services have identified coordination of care
as a serious challenge. The challenges include
ensuring timely access to previous laboratory or imaging
reports at the time of a telehealth visit, scheduling
services so that results are available at the time of
the telehealth visit, and ensuring access to medical
records so that patient and clinician can rely on the
same information during a telehealth visit. We
urge research on the problems and potential solutions
for coordinating care and exploring whether medical
record interoperability and improved patient portals can
enhance care coordination.
Patients who have had
telehealth visits have identified the need for
preparation to ensure a successful visit.
Preparing includes tips about the technology
platform their oncologist is using, reminders about
access to health information on a patient portal or
elsewhere, and reminders about the start and stop time
of a telehealth visit. Patients have suggested a
checklist or updating their personal and medical
information to maximize visit productivity. We
recommend that research address patient preparation for
telehealth visits, as a part of the research on
coordination of care through telehealth.
Researching the
Technological and Practice Obstacles to Receiving
Second Opinions
Cancer patients have said
that they see great promise in access to second opinions
through telehealth visits. Research should explore
professional licensing and other issues required to make
second opinions and consultations readily available
through telehealth. Engaging policymakers will
ensure their input on licensing issues so that second
opinions can be readily offered across state borders.
Additional Issues for
Study
Several other issues have
been identified by providers and patients as topics for
additional research, including:
- Optimal means for
training health care professionals in telehealth
services, including the communication and caring
skills which patients indicate are necessary for
quality visits.
- Provider burnout, which
is a problem among those caring for COVID-19 patients
as well as cancer care clinicians who are adjusting
and adapting to new means of providing care and
maintaining high quality of care during the pandemic.
- The advantages and
disadvantages of telehealth for a first visit with a
new provider (other than a consultation or second
opinion telehealth visit).
- Strategies for ensuring
protection of patient privacy, considering the wide
range of telehealth platforms in use.
- The potential use of
telehealth visits in clinical trials, in the pandemic
and beyond.
- Maximizing the role of
caregivers to ease the delivery of telehealth services
and assist in coordination of care related to
telehealth visits.
We appreciate the
opportunity to offer advice regarding telehealth topics
appropriate for research.
Sincerely,
Cancer
Leadership Council
American Society for
Radiation Oncology
CancerCare
Children’s Cancer Cause
Fight Colorectal Cancer
International Myeloma Foundation
LUNGevity Foundation
Lymphoma Research Foundation
National Coalition for Cancer Survivorship
Ovarian Cancer Research Alliance
Prevent Cancer Foundation
Susan G. Komen
About CLC
| What's New | Policy
Issues | Participants' Login
Home | Sitemap | Contact
Info
Copyright © 2001-2002
Cancer Leadership Council. All rights reserved.
Please send comments and suggestions to
webmaster@cancerleadership.org.
|